ni Ronalyn Seminiano Reonico | December 10, 2020
Inaprubahan na ng Canada ang paggamit ng Pfizer-BioNTech COVID-19 vaccine noong Miyerkules. Saad ng Health Canada, "The data provided supports favourably the efficacy of Pfizer-BioNTech COVID-19 vaccine as well as its safety.
"The efficacy of the vaccine was established to be approximately 95 percent. The vaccine was well tolerated by participants and has no important safety concerns. The benefit-to-risk assessment for Pfizer-BioNTech COVID-19 vaccine is considered favourable."
Pahayag ni Canadian Deputy Chief Public Health Officer Howard Njoo, “At last we have a reason to feel optimistic and excited about returning to the lives we led pre-COVID.”
Paalala naman ni Prime Minister Justin Trudeau, “It doesn’t mean we can let our guards down.”
Samantala, naaprubahan man, hindi pa rin sigurado kung gaano katagal ang efficacy ng Pfizer vaccine kaya magsasagawa pa rin umano ng "risk management plan" ang Health Canada upang ma-monitor ang tagal ng bisa nito at makakalap ng iba pang data para rito.
Komentarji